Conditions: Cystic Fibrosis
Intervention Type: Drug
Intervention Name: Aerosolized, human, plasma-derived Alpha-1 Antitrypsin
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "Aerosolized, human, plasma-derived Alpha-1 Antitrypsin" on "Cystic Fibrosis".
-
Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
NCTID: NCT00499837
